Valuation: Abbott India Limited

Capitalization 58TCr 642.04Cr 543.48Cr 498.11Cr 471.76Cr 875.99Cr 915.86Cr 5.79TCr 2.29TCr 28TCr 2.41TCr 2.36TCr 1,00800Cr P/E ratio 2026 *
37.5x
P/E ratio 2027 * 33.3x
Enterprise value 56TCr 617.35Cr 522.59Cr 478.96Cr 453.63Cr 842.32Cr 880.66Cr 5.57TCr 2.2TCr 27TCr 2.32TCr 2.27TCr 97TCr EV / Sales 2026 *
7.95x
EV / Sales 2027 * 7.2x
Free-Float
24.47%
Yield 2026 *
1.68%
Yield 2027 * 1.87%
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.38%
1 week+0.59%
Current month-0.71%
1 month-2.01%
3 months-6.84%
6 months-16.73%
Current year-5.47%
More quotes
1 week 26,789.05
Extreme 26789.05
28,129
1 month 26,560.05
Extreme 26560.05
28,535.7
Current year 26,560.05
Extreme 26560.05
28,600
1 year 26,560.05
Extreme 26560.05
35,921.55
3 years 19,900
Extreme 19900
35,921.55
5 years 14,250
Extreme 14250
35,921.55
10 years 3,996
Extreme 3996
35,921.55
More quotes
Manager TitleAgeSince
Director of Finance/CFO 52 06/05/2025
Chief Tech/Sci/R&D Officer - -
Compliance Officer - 14/09/2023
Director TitleAgeSince
Chairman 82 01/01/1968
Director/Board Member 69 01/03/2011
Director/Board Member 62 25/04/2018
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.38%+0.59%-7.36%+31.72% 642.04Cr
+3.66%+2.03%+20.48%+210.56% 95TCr
+0.93%+5.61%+56.73%+46.68% 58TCr
+2.01%+0.19%+17.22%+54.51% 39TCr
-0.07%+0.42%+22.51%+25.09% 37TCr
+1.82%+10.57%+39.70%+14.34% 30TCr
-0.47%+0.17%+20.02%+25.68% 30TCr
+0.60%+2.97%+24.53%+50.73% 30TCr
+6.51%-15.65%-48.87%-34.92% 21TCr
+4.49%+12.41%+30.93%+60.00% 21TCr
Average +0.99%+1.97%+17.59%+48.44% 36.04TCr
Weighted average by Cap. +0.87%+2.75%+24.61%+80.34%
See all sector performances

Financials

2026 *2027 *
Net sales 7.04TCr 78Cr 66Cr 60Cr 57Cr 105.95Cr 110.77Cr 700.13Cr 277.17Cr 3.39TCr 291.23Cr 285.23Cr 12TCr 7.7TCr 85Cr 72Cr 66Cr 62Cr 115.92Cr 121.2Cr 766Cr 303.25Cr 3.71TCr 318.62Cr 312.07Cr 13TCr
Net income 1.55TCr 17Cr 14Cr 13Cr 13Cr 23Cr 24Cr 154.2Cr 61Cr 745.91Cr 64Cr 63Cr 2.69TCr 1.75TCr 19Cr 16Cr 15Cr 14Cr 26Cr 28Cr 174.09Cr 69Cr 842.15Cr 72Cr 71Cr 3.03TCr
Net Debt -2.24TCr -25Cr -21Cr -19Cr -18Cr -34Cr -35Cr -222.53Cr -88Cr -1.08TCr -93Cr -91Cr -3.88TCr -2.77TCr -31Cr -26Cr -24Cr -22Cr -42Cr -44Cr -275.44Cr -109.04Cr -1.33TCr -114.57Cr -112.21Cr -4.8TCr
More financial data * Estimated data
Logo Abbott India Limited
Abbott India Limited is an India-based company engaged in the pharmaceuticals business. The Company is involved in product development, manufacturing, and sales of healthcare products. It operates in a single reportable business segment, which is Pharmaceuticals. It distributes products and solutions in multiple therapeutic categories such as women's health, gastroenterology, cardiology, metabolic disorders, Central Nervous System, Vaccines, Multi-Specialty, and primary care. Its products include Colospa (irritable bowel disease), Ganaton (gastrointestinal motility), Librax (irritable bowel disease), Thyronorm (hypothyroidism), Duphaston (miscarriage and IVF), Duphalac (constipation), Digene (antacid), Prothiaden (pain and depression), Influvac (prevention of influenza), Cremaffin Plus (Constipation), Pankreoflat (indigestion), Brufen P (fever), and Duvadilan (preterm labor). It offers various products under brands such as Similac, PediaSure, Pedialyte, EleCare, Ensure, and Glucerna.
Employees
3,659
More about the company
Date Price Change Volume
09/26/09 27,478.35 +0.38% 276
06/26/06 27,373.40 +0.51% 189
05/26/05 27,235.20 +0.43% 168
04/26/04 27,117.85 +0.92% 147
03/26/03 26,869.65 -1.64% 400

Delayed Quote Bombay S.E., February 09, 2026 at 03:30 pm IST

More quotes
Trader
Investor
Global
-
Quality
ESG MSCI
-
More Ratings

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. ABBOTINDIA Stock